// archives

NEWS: Pharma Marketing

RSS feed for this section
This category contains 18 posts

Integrative Logic Earns 2010 AMY Award for Work with Galderma Labs

By ⋅ May 6, 2010 ⋅ Post a comment

ATLANTA, Ga. /Advertising Industry Newswire/ — Integrative Logic, a leading full-service, integrated database marketing provider, earned a 2010 Atlanta Marketer of the Year (AMY) Award from the Atlanta Chapter of the American Marketing Association for Differin.com. The 2010 AMY Awards are open to corporate and agency marketing professionals in Georgia. Entries are scored according to [...]

Pharmaco Marketing: Eularis Reports Help Do More for Real Growth

By ⋅ April 13, 2010 ⋅ Post a comment

LONDON, U.K. /Advertising Industry Newswire/ — The pharmaceutical industry is facing unprecedented challenges on many fronts – a slew of patient expiries, a lack of blockbusters in the pipeline to replace the patent expiries, decreasing growth in many major markets, generic competition, constantly changing regulatory and competitive environment rendering old tools for analysis obsolete, increased [...]

CityMade Logistics to market Celox™ – Battlefield and hospital tested medical product used to clot blood, stop bleeding

By ⋅ September 16, 2009 ⋅ Post a comment

BUFFALO, N.Y. /Advertising Industry Newswire/ — U.K. Medical products manufacturer MedTrade Products Ltd. has selected CityMade Logistics to manage the sales, marketing and distribution of Celox(TM) blood clotting products throughout the U.S. and Canada. The 10-year-old Buffalo-based company will provide these services through CityMade Logistics – CityMade’s eCommerce, Fulfillment and Logistics division. Celox over-the-counter blood [...]

New report from Eularis: Pharmaceutical eMarketing using Social Media – How to Use It Effectively

By ⋅ September 8, 2009 ⋅ Post a comment

NEW YORK, N.Y. and LONDON, U.K. /Advertising Industry Newswire/ — Eularis is announcing the release of its report “How To Harness The Power Of Social Media In Pharmaceutical eMarketing.” This report puts to rest the issues around “can’t,” and shows Pharmaceutical marketers how they can utilize social media networks effectively to meet their marketing objectives. [...]

Eularis to Hold Pharmaceutical Marketing ROI MasterClass in London

By ⋅ May 18, 2009 ⋅ Post a comment

LONDON, U.K. — Dr. Andree Bates, President of the Pharmaceutical analytics company Eularis, will be delivering a MasterClass on how to tell if you are making the wrong marketing decision. The Pharmaceutical Industry is under significant pressure to consider its costs very carefully. Since marketing budgets often represent a major portion of a company’s cost [...]

Market Research: Eularis Analyzes Pre-Launch Brand Planning with New Pharma Industry Report

By ⋅ November 17, 2008 ⋅ Post a comment

NEW YORK, LONDON, TOKYO — In today’s environment, Pharmaceutical companies find themselves in a bind. Drug launches used to be able to achieve high sales and profits – until recently. Every Pharma company today is hoping to achieve their own immediate winners, the drugs that are successful right from the start and provide years of [...]

Eularis Releases First-Ever Study on ROI of Pre-Launch Named Patient Programs

By ⋅ September 16, 2008 ⋅ Post a comment

NEW YORK, N.Y. — Eularis today announced the release of a first-ever study on the ROI of named patient programmes (NPP), also known as compassionate use programs. The paper, “Implementing a pre-launch named patient programme – evidence of increased market share,” provides pharmaceutical companies with insight and mathematical justification into the cash market share and [...]

STG Media Launches Marketing Effort for Resolve Smoking Cessation Lozenge

By ⋅ September 5, 2008 ⋅ Post a comment

TEMPE, Ariz. — Nearly 1 of every 5 deaths is related to smoking. Cigarettes kill more Americans a year than alcohol, car accidents, suicide, AIDS, homicide and illegal drugs combined. Lung cancer has become the leading cause of cancer death among both men and women, and 87% of lung cancer deaths are caused by smoking. [...]

Branded Pharmaceutical Companies Can Expect to See Sales Drops of up to 70 Percent After Patent Expiration from Generic Competition

By ⋅ July 14, 2008 ⋅ Post a comment

NEW YORK, N.Y. and TOKYO, JAPAN — Branded Pharmaceutical companies are painfully aware of the astronomical growth of Generics competition. By the end of this year, Branded drug patents accounting for sales of more than $80 Billion will expire, resulting in major losses in company profits. In the United States, the Generics Industry claims more [...]

Eularis Addresses Marketing Return at Japanese Pharma Marketing Excellence Conference

By ⋅ May 21, 2008 ⋅ Post a comment

TOKYO and LONDON, UK — Dr. Andree Bates, president of the New York and London-based pharmaceutical analytics company Eularis, delivered a presentation on how to tell if you are making the wrong marketing decision at the Pharmaceutical Marketing Excellence conference in Tokyo, Japan, May 19th. Dr. Bates will delivered a presentation titled, “How to Tell [...]

Pharmaceutical Market Research Summit: Eularis to Address Making the Right Research Decision for ROI

By ⋅ April 22, 2008 ⋅ Post a comment

Dr. Andree BatesNEW YORK, N.Y. and LONDON, U.K. — Dr. Andree Bates, president of the pharmaceutical analytics company Eularis, will be delivering a presentation on Making the Right Research Decision for ROI – The Link Between Research and Decisions on Bottom Line Return.

Eularis Exposes Hidden Barriers to Patient Adherence with New Pharmaceutical Industry Report

By ⋅ March 14, 2008 ⋅ Post a comment

NEW YORK, N.Y. and LONDON, U.K. — Costing the global pharmaceutical industry an estimated $30 billion per year and causing an estimated 125,000 deaths per year in the United States, patient non-adherence is a looming issue in the healthcare industry. Eularis has responded to this problem with a new report, available today, titled, “Ensuring Profitable Patient Adherence Programs.”

Eularis to Address Marketing Return at Measuring Marketing ROI in Pharma Conference in London

By ⋅ March 11, 2008 ⋅ Post a comment

NEW YORK, N.Y. and LONDON, U.K. — Dr. Andree Bates, president of the pharmaceutical analytics company Eularis, will be delivering a presentation on meeting the challenges of measuring ROI within the changing dynamics of the pharma industry. On Wednesday 26 March 2008, Dr. Bates will deliver a presentation titled, “Are You Up to the Challenge of Measuring ROI in Changing Dynamics of the Pharma Industry?”

Myo-Med, Tom Brady and STG Media Corp. Team Up to Tackle 2008 Advertising Campaign

By ⋅ March 5, 2008 ⋅ Post a comment

quarterback Tom BradyTEMPE, Ariz. — Superbowl quarterback, Tom Brady has agreed to be the face of Myo-Med, for the launch of their 2008 media campaign. BioForce, the makers of Myo-Med, recently appointed STG Media Corp. as their agency of record to assist them in creating brand awareness among athletes and arthritis sufferers nationwide.

Saatchi & Saatchi Healthcare Communications Group Teams with Google and Yahoo! in Tech Circuit Training

By ⋅ February 7, 2008 ⋅ Post a comment

NEW YORK, N.Y. — Brand teams at a leading New York healthcare communications group are taking their digital skills to the next level at a day-long Tech Fit fair on Tuesday, February 12, 2008, at Saatchi & Saatchi Healthcare Communications Group (SSHCG) headquarters in lower Manhattan. According to Sam Welch, SSHCG president, “Tech Fit isn’t the usual show and tell one-off. It is the latest innovation in SSHCG’s ongoing program of digital training.”

Eularis to Address Marketing Return at Pharmaceutical Marketing Society Half-day Conference in London

By ⋅ November 20, 2007 ⋅ Post a comment

NEW YORK, N.Y. and LONDON, U.K. — Dr. Andree Bates, president of the pharmaceutical analytics company Eularis, will be delivering a presentation on marketing return at the Pharmaceutical Marketing Society Half-day Conference: ROI or RIP. At 2:30 p.m. on Monday 26 November 2007, Dr. Bates will deliver a presentation titled, “What Can Be Measured?”

Marketing Research: Maximizing the Bottom Line in Pharmaceutical Marketing

By ⋅ November 1, 2007 ⋅ Post a comment

LONDON, U.K. — Eularis is announcing the release of an update to its report, “Ensuring Profitable Return-on-Investment (ROI) in Pharmaceutical Marketing: Using Analytics and Metrics to Improve the Bottom Line.” Originally offered in February 2007, the comprehensive report has been revised to provide pharmaceutical marketers with a competitive edge and the latest research information.

Eularis is Reshaping Pharmaceutical Analytics Under New Corporate Identity

By ⋅ September 24, 2007 ⋅ Post a comment

NEW YORK, N.Y. and LONDON, U.K. — Campbell Belman, an established pharmaceutical analytics company, today introduces its new name: Eularis. This announcement reflects the significant growth the Company has achieved across its full range of pharmaceutical analytics products, which have helped tailor the advertising and marketing programs of its global top-tier clients.

—

Resources

Press Release Writing Service
Free News Feeds
Journalist Tools
Culture Blog